SACCO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 55
AS - Asia 47
NA - Nord America 24
Totale 126
Nazione #
CN - Cina 28
IT - Italia 25
US - Stati Uniti d'America 24
SG - Singapore 19
RU - Federazione Russa 10
SE - Svezia 8
FI - Finlandia 6
DE - Germania 3
CH - Svizzera 1
IE - Irlanda 1
NL - Olanda 1
Totale 126
Città #
Shanghai 10
Singapore 9
Lappeenranta 5
Rome 5
Dallas 4
Kassel 3
Milan 3
Verona 3
Ashburn 2
Genoa 2
Guangzhou 2
Padova 2
Portici 2
Rubano 2
Shenzhen 2
Xi'an 2
Beijing 1
Dublin 1
Helsinki 1
Lawrence 1
Princeton 1
Seattle 1
Springfield 1
Vaprio d'Adda 1
Zurich 1
Totale 67
Nome #
Early integration of palliative care in oncology practice: Results of the Italian Association of Medical Oncology (AIOM) survey 32
Molecular diagnostics in the prenatal age: technological evolution and ethical implications in reproductive medicine|La diagnostica molecolare in epoca prenatale: evoluzione tecnologica ed implicazioni etiche in medicina della riproduzione 22
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 14
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study 11
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: Retrospective cohort study 11
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19 11
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 10
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality 10
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 9
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 9
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 7
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study 7
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022 7
Totale 160
Categoria #
all - tutte 1.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2022/202320 3 2 1 0 2 2 3 0 4 0 3 0
2023/202473 1 3 3 10 1 2 0 4 31 2 3 13
2024/202566 25 5 9 17 10 0 0 0 0 0 0 0
Totale 160